Wyeth saw revenues increase 5% in the second quarter of the year to $5.9 billion, contributing to six month sales …
Sanofi-Aventis has snapped up UK biotech Acambis for £276 million, gaining access to an early-stage pipeline of vaccine candidates targeting …
A delay to a key new product took the shine off Lilly's strong second quarter, which saw sales increase 11% …
Sanofi-Aventis' proposed takeover of Zentiva is a step closer to success after its only rival for the Czech generics company …
Sanofi-Aventis had a below par second quarter and faces a generic threat to sales of top-selling drug Plavix in Germany. …
AstraZeneca's second quarter sales increased by 9% to $8 billion, as it rode out a 4% drop in US sales …
When I came to interview Kate Spall, it was she, not I, who fired the first few questions. Her approach …
NICE will receive a record £100 million from the government in attempt to end the UK's postcode lottery and speed …
If you look at your organisation carefully, it is likely you will find three or even four generations represented among …
Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …
In the headlong race for global domination, pharma companies are in the process of flattening their hierarchies, slashing bureaucracy, streamlining …
Teva is to buy rival firm Barr for $7.5 billion to create a new giant in the global generics industry. …
Roche has bought Mirus Bio for $125 million, a move which it believes will put it at the forefront of …
Pfizer has posted strong second quarter results despite underwhelming performance from its US operations. Outside the US Pfizer's revenue rose …
Local communities, businesses, charities and other groups need to come together in a 'national movement' in order to tackle the …
Immunisation against S. aureus has potential in selected target groups Staphylococcus aureus bacteria have become a key concern in both …
Novartis has surpassed estimates for its second quarter performance, boosted by higher than expected sales of its flagship cardiovascular and …
AstraZeneca is training staff in a new Code of Conduct that aims to ensure employees at all levels and locations …